Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies
- PMID: 30188512
- PMCID: PMC6372711
- DOI: 10.1038/s41386-018-0191-9
Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies
Abstract
Use of alcohol, cannabis and opioids is highly prevalent and is associated with global disease burden and high economic costs. The exact pathophysiology of abuse or addiction associated with these sedative substances is not completely understood, but previous research implicates the important role of the striatal dopamine system in the addiction process. Multiple studies investigated changes in the striatal dopamine systems of users of sedative substances, but currently these results are very heterogeneous. Therefore, we conducted a meta-analysis of in vivo neuroimaging studies investigating dopaminergic alterations in the striatum of users of alcohol, opioids or cannabis. Analyses for each substance were conducted separately for the availability of D2/D3 dopamine receptors, dopamine transporters and dopamine synthesis capacity. In total, 723 substance users and 752 healthy controls were included. The results indicated a significant lower striatal D2/D3 receptor availability in alcohol users compared to controls (g = 0.46) but no difference in dopamine transporter availability or dopamine synthesis capacity. Our analysis indicated that changes of dopamine receptors and transporters are moderated by the duration of abstinence. Comparing opioid users with controls revealed a significant lower D2/D3 receptor availability (g = 1.17) and a significantly lower transporter availability (g = 1.55) in opioid users. For cannabis users, there was no significant difference in receptor availability compared to controls and too few studies provided information on dopamine transporter availability or synthesis capacity. Our analysis provides strong evidence for a central role of the striatal dopamine system in use of alcohol or opioids. Further studies are needed to clarify the impact of the dopamine system in cannabis users.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6372711/bin/41386_2018_191_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6372711/bin/41386_2018_191_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6372711/bin/41386_2018_191_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6372711/bin/41386_2018_191_Fig4_HTML.gif)
![Fig. 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6372711/bin/41386_2018_191_Fig5_HTML.gif)
Similar articles
-
Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users.Drug Alcohol Depend. 2013 Feb 1;128(1-2):52-7. doi: 10.1016/j.drugalcdep.2012.07.016. Epub 2012 Aug 19. Drug Alcohol Depend. 2013. PMID: 22909787 Free PMC article.
-
Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.JAMA Psychiatry. 2017 May 1;74(5):511-519. doi: 10.1001/jamapsychiatry.2017.0135. JAMA Psychiatry. 2017. PMID: 28297025 Free PMC article. Review.
-
Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies.Eur Psychiatry. 2019 Jun;59:15-24. doi: 10.1016/j.eurpsy.2019.03.003. Epub 2019 Apr 11. Eur Psychiatry. 2019. PMID: 30981746
-
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability.J Psychopharmacol. 2012 Jan;26(1):144-9. doi: 10.1177/0269881111414090. Epub 2011 Sep 2. J Psychopharmacol. 2012. PMID: 21890594
-
Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies.Psychopharmacology (Berl). 2019 Apr;236(4):1119-1129. doi: 10.1007/s00213-019-05196-1. Epub 2019 Mar 18. Psychopharmacology (Berl). 2019. PMID: 30887059 Free PMC article. Review.
Cited by
-
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.BMJ. 2023 Aug 30;382:e072348. doi: 10.1136/bmj-2022-072348. BMJ. 2023. PMID: 37648266 Free PMC article. Review.
-
Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.Front Psychiatry. 2023 Jun 26;14:1144276. doi: 10.3389/fpsyt.2023.1144276. eCollection 2023. Front Psychiatry. 2023. PMID: 37435402 Free PMC article.
-
Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis.J Psychopharmacol. 2023 Feb;37(2):135-143. doi: 10.1177/02698811221142575. Epub 2022 Dec 12. J Psychopharmacol. 2023. PMID: 36507548 Free PMC article. Review.
-
Intermittent access to oxycodone decreases dopamine uptake in the nucleus accumbens core during abstinence.Addict Biol. 2022 Nov;27(6):e13241. doi: 10.1111/adb.13241. Addict Biol. 2022. PMID: 36301217 Free PMC article.
-
A wireless, implantable optoelectrochemical probe for optogenetic stimulation and dopamine detection.Microsyst Nanoeng. 2020 Aug 24;6:64. doi: 10.1038/s41378-020-0176-9. eCollection 2020. Microsyst Nanoeng. 2020. PMID: 34567675 Free PMC article.
References
-
- United Nations. Office on drugs and crime. World drug report 2017. Vienna: United Nations Publication; 2017.
-
- World Health Organization. Global status report on alcohol and health 2014. Geneva: World Health Organization; 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical